CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 35 filers reported holding CYTOSORBENTS CORP in Q1 2016. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $20 | -99.9% | 1,687 | +16.0% | 0.00% | – |
Q3 2022 | $17,000 | 0.0% | 1,454 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $17,000 | 0.0% | 1,454 | 0.0% | 0.00% | – |
Q1 2022 | $17,000 | – | 1,454 | – | 0.00% | – |
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2020 | $16,000 | 0.0% | 1,967 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $16,000 | – | 1,967 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2018 | $6,000 | -82.9% | 430 | -92.3% | 0.00% | -100.0% |
Q3 2017 | $35,000 | +45.8% | 5,600 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $24,000 | -4.0% | 5,600 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $25,000 | -19.4% | 5,600 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $31,000 | -13.9% | 5,600 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $36,000 | +44.0% | 5,600 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $25,000 | -19.4% | 5,600 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $31,000 | – | 5,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skylands Capital, LLC | 1,126,300 | $8,706,000 | 1.93% |
Sargent Investment Group, LLC | 471,755 | $3,647,000 | 1.68% |
Manatuck Hill Partners, LLC | 125,000 | $966,000 | 0.89% |
Soleus Capital Management, L.P. | 69,600 | $538,000 | 0.63% |
EAM Investors, LLC | 136,098 | $1,052,000 | 0.33% |
Granahan Investment Management | 691,130 | $5,342,000 | 0.29% |
EAM Global Investors LLC | 61,795 | $478,000 | 0.28% |
Winning Points Advisors, LLC | 35,000 | $269,000 | 0.26% |
Leap Investments LP | 14,200 | $110,000 | 0.16% |
Avenir Corp | 150,600 | $1,164,000 | 0.16% |